Compound details
7-Hydroxy-5,4\'-dimethoxy-8-methylisoflavone 7-O-rhamnoside
| Compound ID | CDAMM00608 |
|---|---|
| Common name | 7-Hydroxy-5,4\'-dimethoxy-8-methylisoflavone 7-O-rhamnoside | IUPAC name | 5-methoxy-3-(4-methoxyphenyl)-8-methyl-7-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxychromen-4-one |
| Molecular formula | C24H26O9 |
| Retention time | 13.04 |
|---|---|
| Adduct | [M+NH4]+ |
| Actual mz | 476.186 | Theoretical mz | 476.192 |
| Error | 11.81 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.9026 |
| Inchi key | FBUPXHQDNXCVLC-ZXDQTMQPNA-N |
|---|---|
| Smiles | O=C1C(=COC=2C1=C(OC)C=C(OC3OC(C)C(O)C(O)C3O)C2C)C=4C=CC(OC)=CC4 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Isoflavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction |
| P13726 | F3 | Coagulation factor VII/tissue factor | T72702 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P11387 | TOP1 | DNA topoisomerase I | T09826 | SwissTargetPrediction |
| P01375 | TNF | TNF-alpha | T20178 | SwissTargetPrediction |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| P04062 | GBA | Beta-glucocerebrosidase | T84173 | SwissTargetPrediction |
| P55263 | ADK | Adenosine kinase | T91661 | SwissTargetPrediction |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | T13491 | SwissTargetPrediction |
| O43868 | SLC28A2 | Sodium/nucleoside cotransporter 2 | T94627 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P14151 | SELL | Leukocyte adhesion molecule-1 | T60526 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SwissTargetPrediction and SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SwissTargetPrediction and SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SwissTargetPrediction |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SwissTargetPrediction |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SwissTargetPrediction |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q9NZQ7 | CD274 | Programmed cell death 1 ligand 1 | T99948 | SwissTargetPrediction |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T72702 | DI0075 | Cervical cancer | [ICD-11: 2C77] | P13726 | F3 |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T09826 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11387 | TOP1 |
| T09826 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11387 | TOP1 |
| T09826 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11387 | TOP1 |
| T09826 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P11387 | TOP1 |
| T09826 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11387 | TOP1 |
| T20178 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P01375 | TNF |
| T20178 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P01375 | TNF |
| T20178 | DI0351 | Psoriasis | [ICD-11: EA90] | P01375 | TNF |
| T20178 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P01375 | TNF |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T84173 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | P04062 | GBA |
| T91661 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P55263 | ADK |
| T13491 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q99808 | SLC29A1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T60526 | DI0037 | Asthma | [ICD-11: CA23] | P14151 | SELL |
| T60526 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P14151 | SELL |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T99948 | DI0297 | Neuroendocrine carcinoma | [ICD-11: 2C34] | Q9NZQ7 | CD274 |
| T99948 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9NZQ7 | CD274 |
| T99948 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NZQ7 | CD274 |
| T99948 | DI0423 | Ureteral cancer | [ICD-11: 2C92] | Q9NZQ7 | CD274 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |